Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients

Clinics

Volumn 64, Issue 2, 2009, Pages 79-82

  Salluh, Jorge I F ^a,b   Soares, Márcio ^a   Meis, Ernesto De ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antiphospholipid syndrome; Cancer; Lupus anticoagulant.; Multiple organ failure; Sepsis; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD; CRITICAL ILLNESS; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; IMMUNOLOGY; LARYNX TUMOR; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOSIS;

AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CRITICAL ILLNESS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDIES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOSIS;

EID: 61449235364     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000200003     Document Type: Article

References (16)

1. Miesbach W, Asherson RA, Cervera R, Shoenfeld Y, Gomez Puerta J, Bucciarelli S, et al. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev. 2006;6:94-7.
2. Bairey O, Blickstein D, Monselise Y, Lahav J, Stark P, Prokocimer M, et al. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma. Eur J Haematol. 2006;76:384-91.
3. De Meis E, Pinheiro VR, Loures MA, Kotouc MM, Zamboni MM, Guedes MT, et al. Lupus Anticoagulant Activity as a Thrombosis Risk Factor in Lung Adenocarcinoma Patients. Ann NY Acad Sci. 2007;1107:51-5.
4. Asherson RA. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology. 2005;210:727-33.
5. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis. 2006;65:2-6.
6. Berlin T, Zandman-Goddard G, Blank M, Matthias T, Pfeiffer S, Weis I, et al. Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci. 2007;1108:584-93.
7. Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med. 2005;33:520-26.
8. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32:2416-21.
9. Le Gall JR, Lemeshow S, Saulnier F.A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama. 1993;270:2957-63.
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.
11. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
12. Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5:604-6.
13. Lim W, Crowther MA. Antiphospholipid antibiodies: a critical review of the literature. Curr Opin Hematol. 2007;14:494-9.
14. Wenzel C, Stoiser B, Locker GJ, Laczika K, Quehenberger P, Kapiotis S, et al. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Crit Care Med. 2002;30:763-70.
15. Aldawood AS, Crowther M, Jaeschke R, Dabbagh O, Alkhairy K, Baharoon S, et al. The incidence and impact of lupus anticoagulants among patients in the intensive care unit. Saudi Med J. 2005;26:1994-5.
16. Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 2007;5 Suppl 1:246-54.